Survival benefit of chemotherapy in metastatic colorectal cancer: a meta-analysis of randomized controlled trials
Open Access
- 5 May 2000
- journal article
- research article
- Published by Springer Nature in British Journal of Cancer
- Vol. 82 (11) , 1789-1794
- https://doi.org/10.1054/bjoc.1999.1254
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancerThe Lancet, 1998
- Quantitative Synthesis in Systematic ReviewsAnnals of Internal Medicine, 1997
- Assessing the quality of reports of randomized clinical trials: Is blinding necessary?Controlled Clinical Trials, 1996
- Cost-effectiveness of palliative chemotherapy in advanced gastrointestinal cancerAnnals of Oncology, 1995
- Treatment of liver metastases from colorectal cancer with hepatic artery occlusion, intraportal 5-fluorouracil infusion, and oral allopurinol. A randomized clinical trialCancer, 1994
- Quality of life and survival with continuous hepatic-artery floxuridine infusion for colorectal liver metastasesThe Lancet, 1994
- Randomised comparison of combination chemotherapy plus supportive care with supportive care alone in patients with metastatic colorectal cancer.BMJ, 1993
- Hepatic arterial infusion of floxuridine in patients with liver metastases from colorectal carcinoma: long-term results of a prospective randomized trial.Journal of Clinical Oncology, 1992
- Meta-analysis in clinical trialsControlled Clinical Trials, 1986
- Prospective randomised trial of early cytotoxic therapy for recurrent colorectal carcinoma detected by serum CEA.Gut, 1984